Durvalumab: Solution concentrate for I.V. infusion 120 mg in 2.4 mL, Solution concentrate for I.V. infusion 500 mg in 10 mL; Imfinzi® Page last updated: 6 March 2020 Public Summary Document (PSD) November 2019 PBAC Meeting - (PDF 706KB) Public Summary Document (PSD) November 2019 PBAC Meeting - (Word 181KB)